Donghui Li

599 total citations
8 papers, 438 citations indexed

About

Donghui Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Spectroscopy. According to data from OpenAlex, Donghui Li has authored 8 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Spectroscopy. Recurrent topics in Donghui Li's work include Colorectal Cancer Treatments and Studies (2 papers), Cancer Genomics and Diagnostics (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Donghui Li is often cited by papers focused on Colorectal Cancer Treatments and Studies (2 papers), Cancer Genomics and Diagnostics (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Donghui Li collaborates with scholars based in China, United States and Canada. Donghui Li's co-authors include James L. Abbruzzese, John M. Koomen, Kevin R. Coombes, L. Xiao, Ryûji Kobayashi, Ann G. Schwartz, Nicholas J. Roberts, Alison P. Klein, David B. Zhen and Michael Goggins and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and Journal of Proteome Research.

In The Last Decade

Donghui Li

8 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donghui Li China	6	212	211	150	128	59	8	438
Anupama Mane India	9	109 0.5×	217 1.0×	130 0.9×	66 0.5×	28 0.5×	21	378
Masahiko Nezu Japan	10	63 0.3×	226 1.1×	46 0.3×	48 0.4×	27 0.5×	19	342
Daniel Bastardo Blanco United States	6	115 0.5×	231 1.1×	67 0.4×	24 0.2×	46 0.8×	11	566
Hideaki Iwaki Japan	8	68 0.3×	180 0.9×	63 0.4×	80 0.6×	16 0.3×	22	407
Ailan Cheng China	12	128 0.6×	361 1.7×	134 0.9×	42 0.3×	7 0.1×	28	493
Julia Benzel Germany	9	92 0.4×	115 0.5×	71 0.5×	32 0.3×	14 0.2×	18	263
Mar Haz‐Conde Spain	12	126 0.6×	391 1.9×	289 1.9×	22 0.2×	12 0.2×	14	519
E. McDermott Ireland	10	147 0.7×	233 1.1×	70 0.5×	14 0.1×	136 2.3×	15	438
Shauntae M. McDaniel United States	7	306 1.4×	212 1.0×	120 0.8×	9 0.1×	65 1.1×	7	519
Sun Young Kwun Australia	10	124 0.6×	170 0.8×	96 0.6×	31 0.2×	6 0.1×	11	325

Countries citing papers authored by Donghui Li

Since Specialization

Citations

This map shows the geographic impact of Donghui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donghui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donghui Li more than expected).

Fields of papers citing papers by Donghui Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donghui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donghui Li. The network helps show where Donghui Li may publish in the future.

Co-authorship network of co-authors of Donghui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Donghui Li. A scholar is included among the top collaborators of Donghui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donghui Li. Donghui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Zhao, Bing, Xiaoling Ling, Donghui Li, et al.. (2023). Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China. BMC Cancer. 23(1). 103–103. 5 indexed citations

Hu, Jia, Di Huang, Yanrong Wang, et al.. (2022). The efficacy of immune checkpoint inhibitors in advanced EGFR-Mutated non-small cell lung cancer after resistance to EGFR-TKIs: Real-World evidence from a multicenter retrospective study. Frontiers in Immunology. 13. 975246–975246. 10 indexed citations

Zhao, Hui, Nan Qi, Dianjun Chen, et al.. (2020). STK11/LKB1 revisited: A prognostic rather than predictive biomarker for immune checkpoint inhibitor in EGFR/ALK^WT nonsquamous non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 38(15_suppl). e21548–e21548. 3 indexed citations

Wang, Jia, Yun Ling, Weie Zhou, et al.. (2020). Targeted analysis of six emerging derivatives or metabolites together with 25 common macrolides in milk using Quick, Easy, Cheap, Effective, Rugged and Safe extraction and ultra‐performance liquid chromatography quadrupole/electrostaticfield orbitrap mass spectrometry. Journal of Separation Science. 43(19). 3719–3734. 7 indexed citations

Zhen, David B., Kari G. Rabe, Steven Gallinger, et al.. (2014). BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genetics in Medicine. 17(7). 569–577. 203 indexed citations

Zhu, Hui, Aizhen Yang, Jinfeng Du, et al.. (2013). Basic fibroblast growth factor is a key factor that induces bone marrow mesenchymal stem cells towards cells with Schwann cell phenotype. Neuroscience Letters. 559. 82–87. 29 indexed citations

Eng‐Wong, Jennifer, Susan N. Perkins, Melissa L. Bondy, et al.. (2009). Premenopausal Breast Cancer: Estrogen Receptor Status and Insulin-Like Growth Factor-I (IGF-I), Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3), and Leptin. The Breast Journal. 15(4). 426–428. 7 indexed citations

Koomen, John M., Donghui Li, L. Xiao, et al.. (2005). Direct Tandem Mass Spectrometry Reveals Limitations in Protein Profiling Experiments for Plasma Biomarker Discovery. Journal of Proteome Research. 4(3). 972–981. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact